Correlation of Klebsiella pneumoniae comparative genetic analyses with virulence profiles in a murine respiratory disease model

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Fodah, Ramy A ^a   Scott, Jacob B ^b,d   Tam, Hok Hei ^c   Yan, Pearlly ^d,e   Pfeffer, Tia L ^a   Bundschuh, Ralf ^d,e   Warawa, Jonathan M ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c Massachusetts Institute of Technology Cambridge   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONIN; BACTERIAL PROTEIN; UNCLASSIFIED DRUG; YERSINIABACTIN; BACTERIAL DNA; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTERIAL CAPSULE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CELL CULTURE; CELL FUNCTION; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CONSERVATION; GENETIC CORRELATION; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LOWER RESPIRATORY TRACT INFECTION; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; SEQUENCE ANALYSIS; SEROTYPE; TYPE IV SECRETION SYSTEM; UPPER RESPIRATORY TRACT INFECTION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DISEASE MODEL; DNA SEQUENCE; GENETICS; KLEBSIELLA INFECTION; MICROBIOLOGY; MOLECULAR GENETICS; PROCEDURES; RESPIRATORY TRACT DISEASE; VIRULENCE;

ANIMALS; BACTERIAL PROTEINS; BASE SEQUENCE; CELL LINE; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; GENOME, BACTERIAL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MACROPHAGES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RESPIRATORY TRACT DISEASES; SEQUENCE ANALYSIS, DNA; VIRULENCE; VIRULENCE FACTORS;

EID: 84911376695     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107394     Document Type: Article

References (58)

1. Bagley ST (1985) Habitat association of Klebsiella species. Infect Control 6: 52-58.
2. Kesteman AS, Perrin-Guyomard A, Laurentie M, Sanders P, Toutain PL, et al. (2010) Emergence of resistant Klebsiella pneumoniae in the intestinal tract during successful treatment of Klebsiella pneumoniae lung infection in rats. Antimicrobial agents and chemotherapy 54: 2960-2964.
3. Highsmith AK, Jarvis WR (1985) Klebsiella pneumoniae: selected virulence factors that contribute to pathogenicity. Infect Control 6: 75-77.
4. Chung DR, Song JH, Kim SH, Thamlikitkul V, Huang SG, et al. (2011) High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. American journal of respiratory and critical care medicine 184: 1409-1417.
5. Paganin F, Lilienthal F, Bourdin A, Lugagne N, Tixier F, et al. (2004) Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology 24: 779-785.
6. Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clinical microbiology reviews 11: 589-603.
7. Yu VL, Hansen DS, Ko WC, Sagnimeni A, Klugman KP, et al. (2007) Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerging infectious diseases 13: 986-993.
8. Marrie TJ, Durant H, Yates L (1989) Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Reviews of infectious diseases 11: 586-599.
9. Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, et al. (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 69: 307-316.
10. Marston BJ, Plouffe JF, File TM Jr, Hackman BA, Salstrom SJ, et al. (1997) Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Archives of internal medicine 157: 1709-1718.
11. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, et al. (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcareassociated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America 29: 996-1011.
12. CDC (2009) Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morbidity and mortality weekly report 58: 256-260.
13. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ (1993) Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Annals of internal medicine 119: 353-358.
14. Doyle T, Sanderson R (2008) Survey of hospital microbiology laboratories regarding Klebsiella pneumoniae carbapenemase (KPC)-producing organisms. Epi Update: Florida Department of Health: 9-12.
15. Marquez P, Terashita D (2010) Carbapenem-resistant Klebsiella pneumoniae (CRKP) surveillance Los Angeles County, June-December 2010. Special Studies Report: LA County Public Health: 25-26.
16. Lawlor MS, Hsu J, Rick PD, Miller VL (2005) Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model. Mol Microbiol 58: 1054-1073.
17. Lawlor MS, O'Connor C, Miller VL (2007) Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection. Infect Immun 75: 1463-1472.
18. Lavender HF, Jagnow JR, Clegg S (2004) Biofilm formation in vitro and virulence in vivo of mutants of Klebsiella pneumoniae. Infection and immunity 72: 4888-4890.
19. Padilla E, Llobet E, Domenech-Sanchez A, Martinez-Martinez L, Bengoechea JA, et al. (2010) Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrobial agents and chemotherapy 54: 177-183.
20. March C, Moranta D, Regueiro V, Llobet E, Tomas A, et al. (2011) Klebsiella pneumoniae outer membrane protein A is required to prevent the activation of airway epithelial cells. The Journal of biological chemistry 286: 9956-9967.
21. March C, Cano V, Moranta D, Llobet E, Perez-Gutierrez C, et al. (2013) Role of bacterial surface structures on the interaction of Klebsiella pneumoniae with phagocytes. PLoS ONE 8: e56847.
22. Insua JL, Llobet E, Moranta D, Perez-Gutierrez C, Tomas A, et al. (2013) Modeling Klebsiella pneumoniae pathogenesis by infection of the wax moth Galleria mellonella. Infection and immunity 81: 3552-3565.
23. Izquierdo L, Coderch N, Pique N, Bedini E, Corsaro MM, et al. (2003) The Klebsiella pneumoniae wabG gene: role in biosynthesis of the core lipopolysaccharide and virulence. Journal of bacteriology 185: 7213-7221.
24. Wu KM, Li LH, Yan JJ, Tsao N, Liao TL, et al. (2009) Genome sequencing and comparative analysis of Klebsiella pneumoniae NTUH-K2044, a strain causing liver abscess and meningitis. J Bacteriol 191: 4492-4501.
25. Liu P, Li P, Jiang X, Bi D, Xie Y, et al. (2012) Complete genome sequence of Klebsiella pneumoniae subsp. pneumoniae HS11286, a multidrug-resistant strain isolated from human sputum. Journal of bacteriology 194: 1841-1842.
26. Shin SH, Kim S, Kim JY, Lee S, Um Y, et al. (2012) Complete genome sequence of the 2, 3-butanediol-producing Klebsiella pneumoniae strain KCTC 2242. Journal of bacteriology 194: 2736-2737.
27. Chou HC, Lee CZ, Ma LC, Fang CT, Chang SC, et al. (2004) Isolation of a chromosomal region of Klebsiella pneumoniae associated with allantoin metabolism and liver infection. Infect Immun 72: 3783-3792.
28. Cano V, Moranta D, Llobet-Brossa E, Bengoechea JA, Garmendia J (2009) Klebsiella pneumoniae triggers a cytotoxic effect on airway epithelial cells. BMC Microbiol 9: 156.
29. Brett PJ, Deshazer D, Woods DE (1997) Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol Infect 118: 137-148.
30. Zerbino DR, Birney E (2008) Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome research 18: 821-829.
31. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic acids research 25: 3389-3402.
32. Scott JB (2013) Genetic characterization of the K2 serotype capsule of Klebsiella pneumoniae ATCC 43816 and the development of a bioluminescent strain. Louisville: University of Louisville.
33. Campos MA, Vargas MA, Regueiro V, Llompart CM, Alberti S, et al. (2004) Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun 72: 7107-7114.
34. Bitter T, Muir HM (1962) A modified uronic acid carbazole reaction. Analytical biochemistry 4: 330-334.
35. Donnenberg MS, Kaper JB (1991) Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun 59: 4310-4317.
36. Simon R, Priefer U, Pühler A (1983) A broad range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram-negative bacteria. Bio/Technology 1: 784-791.
37. Struve C, Krogfelt KA (2003) Role of capsule in Klebsiella pneumoniae virulence: lack of correlation between in vitro and in vivo studies. FEMS microbiology letters 218: 149-154.
38. Lawrenz MB, Fodah RA, Gutierrez M, Warawa J (2014) Intubation-mediated intratracheal (IMIT) instillation: A non-invasive, lung-specific delivery system JoVE in press.
39. Hsieh PF, Lin TL, Yang FL, Wu MC, Pan YJ, et al. (2012) Lipopolysaccharide O1 antigen contributes to the virulence in Klebsiella pneumoniae causing pyogenic liver abscess. PLoS ONE 7: e33155.
40. Liao CH, Huang YT, Lai CC, Chang CY, Chu FY, et al. (2011) Klebsiella pneumoniae bacteremia and capsular serotypes, Taiwan. Emerging infectious diseases 17: 1113-1115.
41. Pan YJ, Fang HC, Yang HC, Lin TL, Hsieh PF, et al. (2008) Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype. J Clin Microbiol 46: 2231-2240.
42. Srinivasan VB, Vaidyanathan V, Mondal A, Rajamohan G (2012) Role of the two component signal transduction system CpxAR in conferring cefepime and chloramphenicol resistance in Klebsiella pneumoniae NTUH-K2044. PLoS ONE 7: e33777.
43. Keynan Y, Rubinstein E (2007) The changing face of Klebsiella pneumoniae infections in the community. Int J Antimicrob Agents 30: 385-389.
44. Bachman MA, Oyler JE, Burns SH, Caza M, Lepine F, et al. (2011) Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infection and immunity 79: 3309-3316.
45. Brisse S, Fevre C, Passet V, Issenhuth-Jeanjean S, Tournebize R, et al. (2009) Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One 4: e4982.
46. Fouts DE, Tyler HL, DeBoy RT, Daugherty S, Ren Q, et al. (2008) Complete genome sequence of the N2-fixing broad host range endophyte Klebsiella pneumoniae 342 and virulence predictions verified in mice. PLoS Genet 4: e1000141.
47. Fumagalli O, Tall BD, Schipper C, Oelschlaeger TA (1997) N-glycosylated proteins are involved in efficient internalization of Klebsiella pneumoniae by cultured human epithelial cells. Infection and immunity 65: 4445-4451.
48. Oelschlaeger TA, Tall BD (1997) Invasion of cultured human epithelial cells by Klebsiella pneumoniae isolated from the urinary tract. Infection and immunity 65: 2950-2958.
49. Lau HY, Clegg S, Moore TA (2007) Identification of Klebsiella pneumoniae genes uniquely expressed in a strain virulent using a murine model of bacterial pneumonia. Microb Pathog 42: 148-155.
50. Sahly H, Podschun R, Oelschlaeger TA, Greiwe M, Parolis H, et al. (2000) Capsule impedes adhesion to and invasion of epithelial cells by Klebsiella pneumoniae. Infection and immunity 68: 6744-6749.
51. Kabha K, Nissimov L, Athamna A, Keisari Y, Parolis H, et al. (1995) Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae. Infection and immunity 63: 847-852.
52. Pan PC, Chen HW, Wu PK, Wu YY, Lin CH, et al. (2011) Mutation in fucose synthesis gene of Klebsiella pneumoniae affects capsule composition and virulence in mice. Experimental biology and medicine 236: 219-226.
53. Pan YJ, Lin TL, Hsu CR, Wang JT (2011) Use of a Dictyostelium model for isolation of genetic loci associated with phagocytosis and virulence in Klebsiella pneumoniae. Infection and immunity 79: 997-1006.
54. Yeh KM, Kurup A, Siu LK, Koh YL, Fung CP, et al. (2007) Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. Journal of clinical microbiology 45: 466-471.
55. Lin JC, Chang FY, Fung CP, Xu JZ, Cheng HP, et al. (2004) High prevalence of phagocytic-resistant capsular serotypes of Klebsiella pneumoniae in liver abscess. Microbes and infection/Institut Pasteur 6: 1191-1198.
56. Warawa JM, Long D, Rosenke R, Gardner D, Gherardini FC (2011) Bioluminescent diagnostic imaging to characterize altered respiratory tract colonization by the Burkholderia pseudomallei capsule mutant. Frontiers in microbiology 2: 133.
57. Yadav V, Sharma S, Harjai K, Mohan H, Chhibber S (2003) Induction & resolution of lobar pneumonia following intranasal instillation with Klebsiella pneumoniae in mice. The Indian journal of medical research 118: 47-52.
58. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, et al. (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. The Journal of experimental medicine 194: 519-527